Xcellerex is revolutionizing the way biomolecules are developed, manufactured, and commercialized. The company’s unique single-use technology platform transforms biomanufacturing economics, enabling the development of biotherapeutics and vaccines, and dramatically improving the ability of Xcellerex and its partners to deploy manufacturing capacity.
Xcellerex is a technology and equipment company, but our roots are in designing and running biomanufacturing operations. As a result, we structured the company to include a unique blend of expertise and services that we know to be essential to smoothing our clients’ pathway to new biomanufacturing capacity.
To date, more than 20 therapeutic proteins and vaccines have been manufactured for clinical trials using Xcellerex technology.